Physician

Arthur Joseph Delahoussaye, MD

According to 2025 Medicare claims, Arthur Delahoussaye, MD (NPI: 1932106978) practices ophthalmology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is SEECA MEDICAL INC (NPI: 1851410948; TIN: 621733820) and primary practice location at 70360-2769.

Delahoussaye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 873 traditional Medicare patients, billed 7,990 HCPCS/CPT codes, and received $478,658 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 8,302 prescription claims across 1,395 beneficiaries totaling $428,924 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 5 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $128,594 to $428,924. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$309K$618K2015 Medicare payment: $461,328 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $487,172 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $618,215 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $615,201 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $580,044 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $446,415 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $431,576 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $448,487 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $530,082 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $478,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1626,982$461,328
20161,2777,920$487,172
20171,4139,942$618,215
20181,4109,976$615,201
20191,35210,080$580,044
20201,1767,930$446,415
20219787,463$431,576
20229237,747$448,487
20239659,600$530,082
20248737,990$478,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$214K$429K2015 Drug cost: $128,594 (USD; Tot_Drug_Cst)2016 Drug cost: $167,028 (USD; Tot_Drug_Cst)2017 Drug cost: $204,356 (USD; Tot_Drug_Cst)2018 Drug cost: $222,725 (USD; Tot_Drug_Cst)2019 Drug cost: $224,111 (USD; Tot_Drug_Cst)2020 Drug cost: $194,471 (USD; Tot_Drug_Cst)2021 Drug cost: $239,761 (USD; Tot_Drug_Cst)2022 Drug cost: $325,434 (USD; Tot_Drug_Cst)2023 Drug cost: $400,497 (USD; Tot_Drug_Cst)2024 Drug cost: $428,924 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153741,739$128,594
20164492,078$167,028
20175772,776$204,356
20186673,252$222,725
20197383,568$224,111
20207353,156$194,471
20217953,692$239,761
20228534,010$325,434
20231,1956,041$400,497
20241,3958,302$428,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye231275$104
92014Established patient complete exam of visual system6951,654$82
92012Established patient problem focused exam of visual system4962,140$59
92134Imaging of retina275371$27
92250Photography of the retina364458$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast1003,000$69,834
RestasisCyclosporine1003,240$68,613
RhopressaNetarsudil Mesylate1053,818$40,970
Brimonidine TartrateBrimonidine Tartrate37314,929$40,302
Prednisolone AcetatePrednisolone Acetate1,23130,675$39,454

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$111ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arthur Joseph Delahoussaye, MD?

Tedicare shows public-source Medicare data for Arthur Joseph Delahoussaye, MD (NPI 1932106978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arthur Joseph Delahoussaye, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arthur Joseph Delahoussaye, MD?

Arthur Joseph Delahoussaye, MD is linked to SEECA MEDICAL INC (billing NPI 1851410948) in the available physician profile data.

Does Arthur Joseph Delahoussaye, MD have Open Payments data?

Arthur Joseph Delahoussaye, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.